Drug interactions between Adalat CC and Procardia XL
|Adalat CC (nifedipine)|
|Procardia XL (nifedipine)|
Interactions between your drugs
There were no interactions found in our database between Adalat CC and Procardia XL - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Adalat CC is in the drug class calcium channel blocking agents.
- Adalat CC is used to treat High Blood Pressure.
- Procardia XL is a member of the drug class calcium channel blocking agents.
- Procardia XL is used to treat High Blood Pressure.
Drug and food interactions
Applies to: Adalat CC (nifedipine) and Procardia XL (nifedipine)
You should avoid or limit the consumption of grapefruit and grapefruit juice if you are receiving treatment with NIFEdipine. Grapefruit juice can significantly increase the blood levels and effects of medications like NIFEdipine. You may be more likely to experience side effects such as headache, low blood pressure, irregular heartbeat, swelling, and fluid retention. Talk to your doctor or pharmacist if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Calcium channel blockers
The recommended maximum number of medicines in the 'calcium channel blockers' category to be taken concurrently is usually one. Your list includes one medicines belonging to the 'calcium channel blockers' category:
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.